R

RESTART LIFE Sciences

Investor Platform
BACK HOME CSE: HEAL
Multi-Brand Wellness & CPG Portfolio

Scaling CPG & Functional "Better-for-You" Brands

Building a scalable portfolio of high-margin functional nutrition brands through proprietary formulations, university-backed innovation, and strategic brand development.

Corporate Profile

Restart Life Sciences Corp.

Restart Life Sciences Corp. (CSE: HEAL) is a Canadian life sciences company building a highly scalable, revenue-generating portfolio of science-backed functional food brands. Our growth is driven by disciplined, accretive acquisitions and rapid organic expansion within the high-growth "better-for-you" CPG sector.

By leveraging our wholly-owned, turnkey manufacturing operations in British Columbia, we eliminate third-party bottlenecks to drive immediate, high-margin efficiencies. Supported by an expansive North American retail network and strategic R&D collaboration with the University of Manitoba, Restart holds a strong competitive moat to scale aggressively across global markets.

Incubation Strategy Consolidated Operations

Centralized warehousing, ingredient sourcing, and co-packing arrangements capture immediate margin efficiencies across the portfolio.

University Validation Richardson Centre Collaboration

Collaborating directly with the University of Manitoba (RCFTR) to formulate proprietary, professionally validated, nutrient-dense lines.

Omnichannel Scale Predictive AI Systems

Deploying custom automated checkout, dynamic cart-recovery loops, and predictive inventory models to accelerate digital sales.

Diversified Assets

Our Multi-Brand CPG & IP Portfolio

Constructing a scalable, robust, high-margin wellness asset framework that matches consumer megatrends.

Flagship Asset

Holy Crap Foods Inc.

100% Owned

An internationally recognized clean-food pioneer built on ancient superseeds (Chia, Buckwheat, Hemp) designed for digestive wellness. Selected by NASA/CSA for the International Space Station and a legacy Dragons' Den success.

Retail Footprint 800+ Stores
Revenue $1M+
Smart Nutrition

BrainQ™

100% Owned

Smart Nutrition Starts Here. BrainQ™ isn't just another cereal—it's your brain's best breakfast companion. Formulated with carefully selected, scientifically-backed ingredients to promote brain health and provide sustained, clean energy throughout your day.

Stage Pre-Launch
Target Cognitive Clarity
Functional Snacking

Brain Balls™

Joint Venture

Fuel Your Mind, Anytime. Built via Joint Venture with Brain Balls Inc. to deliver clean, effective, results-driven plant-based fuel for the mind and body. A functional snack designed to support cognitive performance, focus, and mental clarity.

Stage Development
Target Snack Balls
Intellectual Property Leverage

Strategic Trademark Licensing Agreement

Restart Life Sciences has secured exclusive, long-term licensing rights to several premium health-related trademarks under an initial 5-year agreement, with a built-in option to renew for an additional 5 years.

The licensed portfolio includes a proven health-care brand featuring historical Amazon sales.

Agreement Highlights
  • Initial 5-Year Term: Plus 5-year extension option.
  • Nominal Licensing Fee: Low overhead structure.
  • Flexible Royalty Options: Royalties payable in cash or common shares.
Financial Momentum

Demonstrated Multi-Year Growth Trajectory

Disclaimer: The financial metrics, historical figures, and interactive scenarios presented throughout this platform are for presentation and illustrative purposes only, and should not be construed as verified audited public records or formal investment advice.

Revenue Scale
$1.08M CAD
FY 2025 Actual Sales

Record High-Volume CPG Year

Growth Velocity Compound
+35.2%
Total Sales Run-Rate Gain

2021 ($798k) vs 2025 ($1.08M)

Velocity Surge
+64.2%
June YoY Revenue Surge

June 2026 vs June 2025

Logistics & Supply
151,680+
Annual Units Shipped

Sustainable Retail Turn

Acquisition Leverage
4.8x Ratio
DTC Unit Economics

Highly Profitable Sourcing Loop

Consolidated Volume Total
$5.53M CAD
Total Sales (2021-2026)

Cumulative Portfolio Scale

Market Adoption
845,000+
Units Sold Since 2021

Proven Mass Market Demand

Margin Efficiency 61.2%
61.2% Margin
Gross Margin Profile

Consolidated BC Supply Chain

Multi-Year Sales Scale ($ CAD)

+7.81% CAGR

Core Product Blend Volume (YTD)

📈 Core Brand Progress & Operational Statistics

7.81% Historical CAGR Steady, audited brand scaling since 2021 provides a reliable, secure baseline for high-yield market operations.
800+ Active Retail Stores Widespread distribution anchors brand equity across premium groceries (Whole Foods, London Drugs, Save-On-Foods).
64.2% YoY Monthly Surge June 2026 sales reached an unmitigated monthly record of $110,000 CAD, validating post-acquisition integrations.
10+ Premium SKUs Active Holy Crap has achieved a scalable product mix (Natural, Apple Cinnamon, Blueberry Apple, Mango Coconut, and their 1KG variants) driving stable volume.

📊 Advanced Investor Scenario Modeler & Live Runway Projections

Disclaimer: The financial metrics, historical figures, and interactive scenarios presented throughout this platform are for presentation and illustrative purposes only, and should not be construed as verified audited public records or formal investment advice.

GLOBAL EXPANSION MODELING (USD)
HOLY CRAP FOODS MODELING
BRAINQ & OTHER BRANDS MODELING
Incremental Revenue Translations
Retail Footprint: +$0 CAD/yr
AOV Optimization: +$0 CAD/yr
HCF Monthly Boost: +$0 CAD/yr
Existing Exp: +$60,000 CAD/yr
New Launches: +$240,000 CAD/yr
2026/27 R&D: +$120,000 CAD/yr
HCF Bag Sales: +$200,000 CAD/yr
Holy Crap Growth: +$0 CAD/yr
BrainQ & JV Annual: +$0 CAD/yr
USA Annual (CAD): +$0 CAD/yr
Int'l Annual (CAD): +$0 CAD/yr
Live Growth Run-rate projection ($ CAD)

Note: Every +$10K of monthly sales translates directly into +$120K annual run-rate. Global inputs are in USD and converted to CAD at standard corporate FX (1.36 CAD/USD).

Portfolio Total $1,080,034 CAD
Est. Profit (~25%) $270,009 CAD
Implied Revenue P/S $0.017 CAD Based on 62,356,542 shares
R&D and Innovation

University of Manitoba Partnership

Restart Life Sciences is actively leveraging the world-class food science infrastructure at the Richardson Centre for Food Technology and Research (RCFTR) at the University of Manitoba. This collaboration translates cutting-edge gut health research and targeted bio-compounds into scalable commercial products.

Next-Gen Protein Frameworks Refining plant-based protein profiles using RCFTR pilot facilities.
Pre-Production Phase Transition Moving completed formulations directly to commercial production lines.
Visual Rollout

Commercialization Pipeline

Active Core Superseed

Flagship line actively scaling across 800+ national retail locations.

Fall 2026 Holy Crap Protein+ Launch

Pre-production scaling for active lifestyle sectors.

Late 2026 HC Kids

Holy Crap product line rebranded as HC for Kids.

Late 26 / Early 27 Seniors Formula

Geriatric nutrition for metabolic support.

2027 BrainQ & BrainBalls

Cognitive focused snacks

2027 TBA

More is in the works!

Corporate Development

Strategic M&A & Integration Playbook

Restart Life Sciences scales not only through organic product innovation but through disciplined asset acquisition. We target structurally undervalued wellness brands with high loyalty profiles and instantly transition them onto our optimized operating platform.

M&A TARGET CRITERIA Top-Line Accretion • IP Ownership • Brand Synergy
🏭

Case Study: Holy Crap

Beyond acquiring a legacy brand, Restart secured a fully operational, federally compliant manufacturing facility in British Columbia.

This dedicated infrastructure gives Restart logisitical sovereignty, allowing the team to bypass low-margin third-party co-packers. It acts as a rapid launchpad, capable of scaling new SKUs from development to mass distribution in weeks.

Capital Structure

Capital Markets & Regulatory Disclosures

Capital Structure Summary

Common Shares Issued
62,356,542 Latest CSE Record
Reserved for Issuance 17,345,334
Fully Diluted Shares 79,701,876
Corporate Stock Symbol CSE: HEAL
Transfer Agent Olympia Trust
Cross-Exchange Access
FSE: HN30 OTC Pink: NMLSF

Stock Price Performance (CSE: HEAL) Active Marketplace

📰

Corporate News & Press Releases

Stay up to date with Restart Life Sciences' latest announcements, filings, and operational developments.

Read Latest News
Independent Auditor Kreston GTA LLP

Comprehensive Public Audit Services

Legal Counsel Lawson Lundell LLP

Corporate Securities Law Experts

Registrar & Transfer Agent Olympia Trust Company

Investor Registry Services Canada

Direct Stakeholder Engagement

Investors Contact Us

Restart Life Sciences Corp. values open dialogue, absolute transparency, and prompt stakeholder response. For details regarding public trading structures, active financings, joint-venture expansions, or media packets, reach out directly to our corporate relations team.

📞
Office (778) 404-0474
✉️
Email Address hello@restartlife.co
R
RESTART LIFE Sciences

Scaling a highly integrated, revenue-generating portfolio of science-backed functional food and wellness brands across North America.

Regulatory Notice

No securities regulatory authority, including the Canadian Securities Exchange (CSE), the British Columbia Securities Commission (BCSC), or the Ontario Securities Commission (OSC), has approved or disapproved of the information contained on this platform. The CSE does not accept responsibility for the adequacy or accuracy of this content.

Not an Offer of Securities

The information provided on this platform is for informational and illustrative purposes only and does not constitute a solicitation, recommendation, or offer to buy or sell any security or financial instrument of Restart Life Sciences Corp. in any jurisdiction.

Forward-Looking Statements & Liability Waiver: This digital platform contains "forward-looking statements" and "forward-looking information" within the meaning of applicable Canadian and United States securities legislation (collectively, "forward-looking statements"). Forward-looking statements are generally identifiable by the use of words such as "may", "will", "should", "continue", "expect", "anticipate", "estimate", "believe", "intend", "plan", "project", or the negative of these words or other variations. Forward-looking statements on this platform include, but are not limited to: financial runway projections, estimated operational margins, expected outcomes of M&A activity, pipeline commercialization timelines (including Holy Crap Protein+, HC Kids, Seniors Formula, BrainQ, and Brain Balls), interactive modeler translations, implied revenue per share, targeted retail expansion, and future product innovations.

These forward-looking statements are based on the current expectations and beliefs of Restart Life Sciences Corp.'s management and are subject to risks, uncertainties, and assumptions that could cause actual results to differ materially from those described. The interactive financial scenario modeler is an illustrative tool only; it assumes constant market conditions and does not guarantee future financial performance. Viewers are cautioned not to place undue reliance on forward-looking statements. By accessing this platform, the viewer acknowledges and irrevocably agrees that Restart Life Sciences Corp., its directors, officers, employees, and affiliates bear absolute zero liability for any direct, indirect, incidental, or consequential damages or investment losses arising from the reliance upon, or use of, any information, models, or data provided herein.

Readers are encouraged to review the Company's continuous disclosure filings on SEDAR+ (www.sedarplus.ca) for a comprehensive outline of the risks and uncertainties affecting the Company's business and financial results. The Company assumes no obligation to update or revise any forward-looking statements, whether as a result of new information, future events, or otherwise, except as required by applicable law.

© 2026 Restart Life Sciences Corp. All Rights Reserved. CSE: HEAL | OTC Pink: NMLSF | FSE: HN30